Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Bayer said it will present late-breaking and poster data from its cardiovascular portfolio at the Heart Failure Society of America annual meeting. The materials include a Phase III post-hoc analysis of investigational iodine 124 evuzamitide and study designs for ongoing finerenone trials.
Bayer said one late-breaking presentation and five posters on its cardiovascular programs will be featured at the Heart Failure Society of America (HFSA) Annual Scientific Meeting in Phoenix from Oct. 9-12, 2026.